• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱癌男性患者根据疾病阶段的导尿管采集尿液中的微生物组。

The Microbiome of Catheter Collected Urine in Males with Bladder Cancer According to Disease Stage.

机构信息

Humanitas Clinical and Research Center, Rozzano, Milan, Italy.

Department of Urology, Humanitas Clinical and Research Center, Rozzano, Milan, Italy.

出版信息

J Urol. 2021 Jan;205(1):86-93. doi: 10.1097/JU.0000000000001336. Epub 2020 Aug 28.

DOI:10.1097/JU.0000000000001336
PMID:32856979
Abstract

PURPOSE

The dogma that urine is sterile has been overturned and dysbiosis of the urinary microbiome has been linked to many urological disorders. We tested the hypothesis that the urinary microbial composition may be different between men with or without bladder cancer in catheter collected urines, bladder washouts and midstream voided urines, and may be dependent on tumor staging.

MATERIALS AND METHODS

Liquid samples were collected from male patients with bladder cancer, and sex and age matched nonneoplastic controls. Total DNA was extracted and processed for 16S rRNA gene sequencing. Bioinformatic analysis for microbial classification was performed to assess diversity and variations.

RESULTS

The urinary microbiome associated with catheter collected urine samples of patients with bladder cancer was characterized by a significantly increased abundance of (p=0.04) and (p=0.03), and decreased (p=0.03) compared to controls, with differences exacerbating with disease progression. Compared to catheterized urines, bladder cancer washouts showed the specific increase of some taxa, like (p=0.014), whereas midstream urines were enriched in (p <0.0001), (p <0.0001), (p=0.038) and (p <0.0001).

CONCLUSIONS

The bladder is colonized by endogenous bacteria and microbial modifications characterize the microbiome of patients with bladder cancer. Different microbial compositions can be characterized by changing sampling strategy. These results pave the way for exploring new diagnostic and therapeutic options based on the manipulation of the bacterial community.

摘要

目的

尿液无菌的教条已被推翻,尿液微生物组的失调与许多泌尿科疾病有关。我们检验了这样一个假设,即在导管采集的尿液、膀胱冲洗液和中段尿样中,患有膀胱癌的男性和不患有膀胱癌的男性的尿液微生物组成可能不同,且这种差异可能依赖于肿瘤分期。

材料与方法

从患有膀胱癌的男性患者和性别及年龄匹配的非肿瘤对照者中采集液体样本。提取总 DNA 并进行 16S rRNA 基因测序。采用生物信息学分析进行微生物分类,以评估多样性和变化。

结果

与膀胱癌患者的导管采集尿液样本相关的尿液微生物组,其特征是 (p=0.04)和 (p=0.03)的丰度显著增加,而 (p=0.03)则减少,且随着疾病进展,这些差异加剧。与导管采集的尿液相比,膀胱癌冲洗液显示出某些分类群的特异性增加,如 (p=0.014),而中段尿液则富含 (p<0.0001)、 (p<0.0001)、 (p=0.038)和 (p<0.0001)。

结论

膀胱被内源性细菌定植,微生物改变特征描述了膀胱癌患者的微生物组。通过改变采样策略,可以对不同的微生物组成进行特征描述。这些结果为探索基于细菌群落操纵的新诊断和治疗方法铺平了道路。

相似文献

1
The Microbiome of Catheter Collected Urine in Males with Bladder Cancer According to Disease Stage.膀胱癌男性患者根据疾病阶段的导尿管采集尿液中的微生物组。
J Urol. 2021 Jan;205(1):86-93. doi: 10.1097/JU.0000000000001336. Epub 2020 Aug 28.
2
Profiling the Urinary Microbiota in Male Patients With Bladder Cancer in China.分析中国男性膀胱癌患者的尿微生物组。
Front Cell Infect Microbiol. 2018 May 31;8:167. doi: 10.3389/fcimb.2018.00167. eCollection 2018.
3
The urinary microbiome associated with bladder cancer.膀胱癌相关的尿微生物组。
Sci Rep. 2018 Aug 14;8(1):12157. doi: 10.1038/s41598-018-29054-w.
4
Sex-specific Alterations in the Urinary and Tissue Microbiome in Therapy-naïve Urothelial Bladder Cancer Patients.治疗初发尿路上皮膀胱癌患者尿和组织微生物组的性别特异性改变。
Eur Urol Oncol. 2020 Dec;3(6):784-788. doi: 10.1016/j.euo.2020.04.002. Epub 2020 Apr 25.
5
Dysbiosis in Human Urinary Microbiota May Differentiate Patients with a Bladder Cancer.人类尿液微生物组的失调可能可以区分膀胱癌患者。
Int J Mol Sci. 2024 Sep 21;25(18):10159. doi: 10.3390/ijms251810159.
6
Dysbiosis signatures of the microbial profile in tissue from bladder cancer.膀胱癌组织中微生物特征的失调特征。
Cancer Med. 2019 Nov;8(16):6904-6914. doi: 10.1002/cam4.2419. Epub 2019 Sep 30.
7
Urinary microbiota and bladder cancer: A systematic review and a focus on uropathogens.尿微生物组与膀胱癌:系统评价及尿路病原体关注焦点
Semin Cancer Biol. 2022 Nov;86(Pt 3):875-884. doi: 10.1016/j.semcancer.2021.12.010. Epub 2022 Jan 1.
8
Changes in the Urinary Microbiome After Transurethral Resection of Non-muscle-Invasive Bladder Cancer: Insights from a Prospective Observational Study.经尿道膀胱肿瘤切除术(非肌层浸润性膀胱癌)后尿微生物组的变化:一项前瞻性观察研究的结果。
Ann Surg Oncol. 2024 Jul;31(7):4773-4786. doi: 10.1245/s10434-024-15198-9. Epub 2024 Apr 3.
9
Bladder cancer is associated with decreased urinary microbiota diversity and alterations in microbial community composition.膀胱癌与尿微生物多样性减少和微生物群落组成改变有关。
Urol Oncol. 2023 Feb;41(2):107.e15-107.e22. doi: 10.1016/j.urolonc.2022.09.018. Epub 2022 Nov 16.
10
Urinary microbiome dysbiosis is associated with an inflammatory environment and perturbed fatty acids metabolism in the pathogenesis of bladder cancer.尿微生物组失调与膀胱癌发病机制中的炎症环境和脂肪酸代谢紊乱有关。
J Transl Med. 2024 Jul 5;22(1):628. doi: 10.1186/s12967-024-05446-7.

引用本文的文献

1
Microbiome Shifts in Bladder Cancer: A Narrative Review of Urobiome Composition, Progression, and Therapeutic Impact.膀胱癌中的微生物组变化:尿微生物组组成、进展及治疗影响的叙述性综述
Medicina (Kaunas). 2025 Aug 1;61(8):1401. doi: 10.3390/medicina61081401.
2
Urinary microbiome and urological cancers: a mini review.泌尿系统微生物群与泌尿系统癌症:一篇小型综述。
Front Urol. 2024 Mar 8;4:1367720. doi: 10.3389/fruro.2024.1367720. eCollection 2024.
3
From dysbiosis to precision therapy: decoding the gut-bladder axis in bladder carcinogenesis.
从生态失调到精准治疗:解读膀胱癌发生过程中的肠-膀胱轴
Front Oncol. 2025 Jul 10;15:1630726. doi: 10.3389/fonc.2025.1630726. eCollection 2025.
4
Exploring bladder cancer through urinary microbiota: innovative "urinetypes" classification and establishment of a diagnostic model.通过尿液微生物群探索膀胱癌:创新的“尿型”分类及诊断模型的建立
J Transl Med. 2025 Jul 22;23(1):809. doi: 10.1186/s12967-025-06518-y.
5
A real-world pharmacovigilance study of efgartigimod alfa in the FDA adverse event reporting system database.在FDA不良事件报告系统数据库中开展的关于阿伐吉莫德的真实世界药物警戒研究。
Front Pharmacol. 2025 Apr 16;16:1510992. doi: 10.3389/fphar.2025.1510992. eCollection 2025.
6
Microbiome landscapes of the bladder, intestine, and vagina in bladder cancer: a systematic review.膀胱癌中膀胱、肠道和阴道的微生物群景观:一项系统综述。
Discov Oncol. 2025 Apr 14;16(1):525. doi: 10.1007/s12672-025-02165-3.
7
The role of urinary microbiota in primary and recurrent bladder cancer: insights from a propensity score matching study.尿微生物群在原发性和复发性膀胱癌中的作用:倾向评分匹配研究的见解
BMC Cancer. 2025 Mar 14;25(1):468. doi: 10.1186/s12885-025-13817-6.
8
Towards Reliable Methodology: Microbiome Analysis of Fresh Frozen vs. Formalin-Fixed Paraffin-Embedded Bladder Tissue Samples: A Feasibility Study.迈向可靠方法:新鲜冷冻与福尔马林固定石蜡包埋膀胱组织样本的微生物组分析:一项可行性研究
Microorganisms. 2024 Dec 15;12(12):2594. doi: 10.3390/microorganisms12122594.
9
Microbiome in urologic neoplasms: focusing on tumor immunity.泌尿系统肿瘤中的微生物群:聚焦肿瘤免疫
Front Immunol. 2024 Dec 5;15:1507355. doi: 10.3389/fimmu.2024.1507355. eCollection 2024.
10
Gut microbiota: a crucial player in the combat against tuberculosis.肠道微生物群:抗击结核病的关键因素。
Front Immunol. 2024 Oct 22;15:1442095. doi: 10.3389/fimmu.2024.1442095. eCollection 2024.